학술논문
Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram-Negative Bacterial Infections: A Phase 1b, Open-Label, Single-Dose Clinical Trial
Document Type
Article
Author
Source
In: Journal of Clinical Pharmacology . (Journal of Clinical Pharmacology, December 2023, 63(12):1387-1397)
Subject
Language
English
ISSN
15524604
00912700
00912700